SLC26A3 and colorectal carcinoma: Our data demonstrate that SLC26A3 enhances the expression of IκB in the presence of NHERF2 (Fig. 6K), thereby impeding the malignant behaviors of CRC cells, including proliferation (Fig. 6L), colony formation (Fig. 6M), migration, and invasion (Fig. 6N, O).